Filippo Schepis

Shunt magnitude is a key determinant of overt hepatic encephalopathy in patients undergoing TIPS

Reconsidering the Relationship Between Early Post Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy and Mortality: Are We Still Missing Something?

Neoadjuvant Under-Dilated TIPS: Expanding Surgeries for Extrahepatic Malignancies in Patients With Cirrhosis and CSPH.

Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient in Clinical Practice: An Investigational Procedure-What Can We Tell Patients?

Rethinking TIPS: From clinical insight to device innovation

The qEEG-TIPS score: Development of a predictive model for recurrent overt hepatic encephalopathy after elective TIPS

Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome.

End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective TIPS in patients with cirrhosis

Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD

End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective TIPS in patients with cirrhosis.

Impact of first and further decompensation in patients with compensated ACLD due to MASLD.

Sedoanalgesia during TIPS placement: Hemodynamic and ethical issues.

Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis.

Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study

Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.

Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome

Reply to: "Does encephalopathy with early onset after TIPS impact on mortality?"

Reply to: "Post-TIPS OHE: Are we really making a mountain out of a molehill?"

Reply to: "Hepatic encephalopathy and survival after transjugular intra-hepatic portosystemic shunt: Do spontaneous portosystemic shunts matter?"

Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to Sex.

Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis.

Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study

Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma.

5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial.

Transjugular Intrahepatic Portosystemic Shunt: Devices Evolution, Technical Tips and Future Perspectives.

Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids.

Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease.

Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patients.

The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions